Back to Interventions

Substance / Medication

Iron carbonyl

SNOMED 32954005 UMLS C0876769

Overview

Active Ingredient

iron carbonyl

RxNorm CUI

262150

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Iron deficiency anemia

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Iron binding capacity

LOINC 2500-7

secondary

LOINC 718-7

primary

LOINC 2498-4

primary

Clinical Trials

18 trials linked to this intervention

18

Total Trials

1

Recruiting

7

With Results

Recent Trials

Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome

NCT00200941Phase 4Completed44 enrolled

Long-term Study Of Ropinirole In Restless Legs Syndrome

NCT00329602Phase 4Completed404 enrolled

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole

NCT00344994Phase 4Completed20 enrolled

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

NCT00349531Phase 4Completed369 enrolled

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

NCT00356096Phase 4Completed404 enrolled

View all 18 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Binuclear cyclopentadienylcobalt carbonyls: comparison with binuclear iron carbonyls.

Wang Hongyan, Xie Yaoming, King R Bruce et al. · J Am Chem Soc · 2005

PMID: 16104740Observational

Iron Carbonyl Complexes of [2.2.2]Hericene as a Rigid Tris(1,3-diene) Ligand.

Luo Jinfeng, Chen Haoyu, Li Huidong et al. · Molecules · 2024

PMID: 39598727OtherFull text (PMC)

Inorganic-organic hybrid Cu-dipyridyl semiconducting polymers based on the redox-active cluster [SFe(CO)]: filling the gap in iron carbonyl chalcogenide polymers.

Hsu Ming-Chi, Lin Ru Yan, Sun Tzu-Yen et al. · Dalton Trans · 2024

PMID: 38587832Other

Decarbonylation Products of Binuclear Methylphosphinidene Complexes of Cyclopentadienyliron Carbonyls: Triplet and Quintet Structures Are Favored Energetically over Singlet Structures with Iron-Iron Multiple Bonding.

Rudenco Oleg, Lupan Alexandru, Silaghi-Dumitrescu Radu et al. · ACS Omega · 2024

PMID: 38496963OtherFull text (PMC)

Substituent Effects and Mechanistic Insights on the Catalytic Activities of (Tetraarylcyclopentadienone)iron Carbonyl Compounds in Transfer Hydrogenations and Dehydrogenations.

Werley Bryn K, Hou Xintong, Bertonazzi Evan P et al. · Organometallics · 2023

PMID: 38028505OtherFull text (PMC)

Polyhedral Ferraboranes with Iron Carbonyl Vertices: Carbonyl Migration Processes in the Iron Tetracarbonyl Derivatives.

Attia Amr A A, Lupan Alexandru, King R Bruce · J Phys Chem A · 2023

PMID: 37433263OtherFull text (PMC)

Paramagnetic {[Fe(CO)]-μ-η:η-η:η-(C)}Dimer Bridged by Iron Atoms and C-C Bonds: Effect of Starting Iron Carbonyls on Structures and Properties of Negatively Charged Iron-Bridged Fullerene Dimers.

Sobov Pavel A, Kuzmin Alexey V, Khasanov Salavat S et al. · Inorg Chem · 2023

PMID: 37850881Other

Generation of Highly Vibrationally Excited CO in Sequential Photodissociation of Iron Carbonyl Complexes.

Nagamori Keigo, Haze Misato, Nakata Hiroyuki et al. · J Phys Chem A · 2022

PMID: 35007077Other

Combining metal-metal cooperativity, metal-ligand cooperativity and chemical non-innocence in diiron carbonyl complexes.

van Beek Cody B, van Leest Nicolaas P, Lutz Martin et al. · Chem Sci · 2022

PMID: 35308864OtherFull text (PMC)

Infrared photodissociation spectroscopy of heteronuclear group 15 metal-iron carbonyl cluster anions AFe(CO)(A = Sb, Bi; m, n = 2, 3).

Meng Luyan, Liu Siying, Qin Qifeng et al. · Phys Chem Chem Phys · 2021

PMID: 34036991Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Internal Medicine Physician

Internal Medicine

NUCC 207R00000X

Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

NUCC 207RH0000X

Find a Provider

Health Goals

Goals connected through associated conditions

Optimize Iron and Blood Health Optimize Nutrient Levels

Quick Facts

Type: Substance / Medication
Fully Specified Name: Iron carbonyl (substance)
SNOMED CT: 32954005
UMLS CUI: C0876769
RxNorm CUI: 262150

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

2

Conditions

3

Biomarkers

2

Specialists

0

Symptoms

18

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.